FRONT LINE GENOMICS LIMITED Filleted Accounts Cover
FRONT LINE GENOMICS LIMITED
Company No. 10421716
Information for Filing with The Registrar
31 January 2024
FRONT LINE GENOMICS LIMITED Directors Report Registrar
The Directors present their report and the accounts for the year ended 31 January 2024.
Principal activities
The principal activity of the company during the year under review was to organise exhibitions and conferences.
Directors
The Directors who served at any time during the year were as follows:
B. LUMB
R. LUMB
The above report has been prepared in accordance with the provisions applicable to companies subject to the small companies regime as set out in Part 15 of the Companies Act 2006.
Signed on behalf of the board
B. LUMB
Director
15 October 2024
FRONT LINE GENOMICS LIMITED Balance Sheet Registrar
at
31 January 2024
Company No.
10421716
Notes
2024
2023
£
£
Fixed assets
Tangible assets
4
51,61458,943
51,61458,943
Current assets
Debtors
5
707,183753,517
Cash at bank and in hand
499,881393,131
1,207,0641,146,648
Creditors: Amount falling due within one year
6
(356,445)
(374,529)
Net current assets
850,619772,119
Total assets less current liabilities
902,233831,062
Net assets
902,233831,062
Capital and reserves
Called up share capital
100100
Profit and loss account
7
902,133830,962
Total equity
902,233831,062
These accounts have been prepared in accordance with the special provisions applicable to companies subject to the small companies regime of the Companies Act 2006.
For the year ended 31 January 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
As permitted by section 444 (5A)of the Companies Act 2006 the directors have not delivered to the Registrar a copy of the company's profit and loss account.
Approved by the board on 15 October 2024 and signed on its behalf by:
B. LUMB
Director
15 October 2024
FRONT LINE GENOMICS LIMITED Notes to the Accounts Registrar
for the year ended 31 January 2024
1
General information
FRONT LINE GENOMICS LIMITED is a private company limited by shares and incorporated in England and Wales.
Its registered number is: 10421716
Its registered office is:
Ground Floor, Cromwell House
15 Andover Road
Winchester
SO23 7BT
The accounts have been prepared in accordance with FRS 102 Section 1A - The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
2
Accounting policies
Turnover
Turnover is measured at the fair value of the consideration received or receivable. Turnover is reduced for estimated customer returns, rebates and other similar allowances.

Revenue from the sale of goods is recognised when all the following conditions are satisfied:
• the Company has transferred to the buyer the significant risks and rewards of ownership of the
goods;
• the Company retains neither continuing managerial involvement to the degree usually associated
with ownership nor effective control over the goods sold;
• the amount of revenue can be measured reliably;
• it is probable that the economic benefits associated with the transaction will flow to the Company;
and
• the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Specifically, revenue from the sale of goods is recognised when goods are delivered and legal title is passed.
Tangible fixed assets and depreciation
Tangible fixed assets held for the company's own use are stated at cost less accumulated depreciation and accumulated impairment losses.

At each balance sheet date, the company reviews the carrying amount of its tangible fixed assets to determine whether there is any indication that any items have suffered an impairment loss. If any such indication exists, the recoverable amount of an asset is estimated in order to determine the extent of the impairment loss.
Depreciation is provided at the following annual rates in order to write off the cost or valuation less the estimated residual value of each asset over its estimated useful life:
Motor vehicles
20% Straight line
Furniture, fittings and equipment
25% Straight line
Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.

The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the profit and loss account because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The Company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.

Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable temporary differences. Deferred tax assets are generally recognised for all deductible timing differences to the extent that it is probable that taxable profits will be available against which those deductible temporary differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.

Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period.

Current or deferred tax for the year is recognised in profit or loss, except when they relate to items that are recognised in other comprehensive income or directly in equity, in which case, the current and deferred tax is also recognised in other comprehensive income or directly in equity respectively.
Trade and other debtors
Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method, less impairment losses for bad and doubtful debts.
Trade and other creditors
Short term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.
Foreign currencies
The functional and presentational currency of the company is Sterling. The accounts are rounded to the nearest pound.
Transactions in currencies, other than the functional currency of the Company, are recorded at the rate of exchange on the date the transaction occurred. Monetary items denominated in other currencies are translated at the rate prevailing at the end of the reporting period. all differences are taken to the profit and loss account. Non-monetary items that are measured at historic cost in a foreign currency are not retranslated.
Defined contribution pensions
The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the company pays fixed contributions into a separate entity. Once the contributions have been paid the company has no further payments obligations.
The contributions are recognised as expenses when they fall due. Amounts not paid are shown in accruals in the balance sheet. The assets of the plan are held separately from the company in independently administered funds.
3
Employees
2024
2023
Number
Number
The average monthly number of employees (including directors) during the year was:
1511
4
Tangible fixed assets
Motor vehicles
Fixtures, fittings and equipment
Total
£
£
£
Cost or revaluation
At 1 February 2023
56,2558,89965,154
Additions
-7,4117,411
At 31 January 2024
56,25516,31072,565
Depreciation
At 1 February 2023
3,7502,4616,211
Charge for the year
11,2513,48914,740
At 31 January 2024
15,0015,95020,951
Net book values
At 31 January 2024
41,25410,36051,614
At 31 January 2023
52,505
6,438
58,943
5
Debtors
2024
2023
£
£
Trade debtors
124,54873,181
Corporation tax recoverable
164,112152,448
Loans to directors
329,422517,583
Other debtors
466950
Prepayments and accrued income
88,6359,355
707,183753,517
6
Creditors:
amounts falling due within one year
2024
2023
£
£
Trade creditors
138,208110,260
Taxes and social security
131,377
206,641
Other creditors
5,8292,896
Accruals and deferred income
81,03154,732
356,445374,529
7
Reserves
Profit and loss account - includes all current and prior period retained profits and losses.
FRONT LINE GENOMICS LIMITED1042171631 January 202401 February 2023false15 October 2024BTCSoftware AP Solution 2024 11.1.0811.1.08true104217162023-02-012024-01-31104217162024-01-31104217162023-01-3110421716core:WithinOneYear2024-01-3110421716core:WithinOneYear2023-01-3110421716core:ShareCapital2024-01-3110421716core:ShareCapital2023-01-3110421716core:RetainedEarningsAccumulatedLosses2024-01-3110421716core:RetainedEarningsAccumulatedLosses2023-01-3110421716countries:UnitedKingdom2023-02-012024-01-3110421716bus:RegisteredOffice2023-02-012024-01-3110421716core:MotorVehicles2023-02-012024-01-3110421716core:FurnitureFittingsToolsEquipment2023-02-012024-01-31104217162022-02-012023-01-3110421716core:MotorVehicles2023-02-0110421716core:FurnitureFittingsToolsEquipment2023-02-01104217162023-02-0110421716core:MotorVehicles2024-01-3110421716core:FurnitureFittingsToolsEquipment2024-01-3110421716core:RetainedEarningsAccumulatedLosses2023-02-012024-01-3110421716bus:SmallEntities2023-02-012024-01-3110421716bus:FullAccounts2023-02-012024-01-3110421716bus:AuditExempt-NoAccountantsReport2023-02-012024-01-3110421716bus:Director12023-02-012024-01-3110421716bus:PrivateLimitedCompanyLtd2023-02-012024-01-31iso4217:GBPxbrli:pure